Amrize initiated with an Equal Weight at Barclays

Barclays initiated coverage of Amrize (AMRZ) with an Equal Weight rating and CHF 41 price target The company’s “various market challenges,” including cement pricing and import risk, Canadian exposure and roofing supply additions, justify the stock’s valuation discount to peers, the analyst tells investors in a research note. Barclays sees “cleaner” U.S. exposure elsewhere in the group.